News & Insights

Biofourmis has been named by Fierce Healthcare as the Digital/Mobile Health Solution Winner and Best in Show Winner for Cost Saving in the Fierce Healthcare Innovation Awards 2021 for hospital at home solution

Integra Community Care Network, Care New England’s accountable care organization (ACO), partners with Biofourmis to deliver personalized care at home to patients in their home hospital program and complex care management program.

Judges lauded Biofourmis’ rapid growth and the ability of its artificial intelligence (AI)-powered Biovitals® platform to remotely collect and analyze clinical biomarkers of trial participants.

We are taking personalized, predictive care to new heights as BioVitalsHF is the first-ever digital medicine to receive a breakthrough exemption from the FDA for patients with heart failure.

Former Amazon Medical Officer and Massachusetts General Hospital Cardiologist to Lead Product Management, Data Science and Clinical Affairs for Biofourmis.

Biofourmis announces national rollout of the Biovitals® Hospital@Home™ platform to help deliver Hospital-Level Care in the home aligned with new CMS Program, providing coverage for hospital at home providers.

Led by SoftBank Vision Fund 2 , Biofourmis closed a $100 Million Series C funding round to accelerate U.S. and Global Expansion

Biovitals has been deployed by the Ministry of Health in Singapore to remotely monitor COVID-19 patients to aid in early detection and to enable clinicians to intervene early.

Chugai Pharmaceutical Co. Ltd and our digital medicine company have partnered to develop an objective assessment of pain using digital technology.